Abstract
Although the ability of pancreatic transplants to establish a normoglycemic insulin–independent state in diabetic humans was shown by Lillehei and Kelly and associates in the late sixties [1,2], technical and immunological problems limited its application for many years. During the past 10 years, however, the cumulative efforts of several international teams have elevated pancreatic transplantation from clinical experimentation to the edge of becoming a routine form of therapy method for selected patients with established or emerging complications of diabetes [3].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kelly WD, Lillehei RC, Merkel FK et al: Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61: 827, 1967.
Lillehei RC, Simmons RL, Najarian JS et al: Pancreaticoduodenal allotransplantation: experimental and clinical experience. Ann Surg 172: 405 – 436, 1970.
Land W, Landgraff R: Clinical pancreas transplantation, the world experience. Proceedings of the second international workshop on clinical pancreas transplantation. Transpl Proc 19 (Suppl No 4): 1 – 95, 1987.
Sutherland DER, Najarian JS, Greenberg BZ et al: Hormonal and metabolic effects of an endocrine graft. Vascularized segmental transplantation on the pancreas in insulin-independent patients. Ann Inter Med 95: 537, 1981.
Pozza G, Traeger J, Dubernard JM et al: Endocrine responses of type I (insulin-independent) diabetic patients following successful pancreas transplantation. Diabetologia 24: 244, 1983.
Malone JI, Hellrung JM, Malphus EW, Rosenbloom AL, Grgic A, Weber FT: Good diabetic control: a study in mass delusion. J Ped 88: 943 – 947, 1976.
Henderson JR, Daniel PM, Frasor PA: The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 22: 158, 1981.
Sutherland DER, Moudry KC: Pancreas transplant registry: history and analysis of cases 1966 to October 1986. Pancreas 2: 473 – 488, 1987.
Sutherland DER, Moudry KC: Pancreas transplant registry: history and analysis of cases 1966 to October 1986. Pancreas 2: 473 – 488, 1987.
Sutherland DER: Report of the international human pancreas and islet transplant registry cases through 1981. Diabetes 31 (Suppl 4): 112 – 116, 1982.
Blanc-Brunat N, Dubernard JM, Touraine JL, et al: Pathology of the pancreas after intraductal neoprene injection in dogs and diabetic patients treated by pancreatic transplantation. Diabetologia 25: 97, 1983.
Goozen HG, Bosman FT, van Schilfgaarde R: The effect of duct obliteration on histology and endocrine function of the canine pancreas. Transplantation 38: 13, 1984.
Rossi RL, Soeldner JS, Braasch JW, Heiss FW, Shea JA, Nugent FW, Watkins E, Silverman ML, Bolton J: Segmental pancreatic autotransplantation with pancreatic ductal occlusion after near total or total pancreatic resection for chronic pancreatitis. Ann Surg 203: 626 – 636, 1986.
Di Carlo V, Chiesa R, Pontiroli, AE, Pozza G, Carlucci M, Staudacher C, Secchi A, Cristallo M: Intraductal injection of neoprene to suppress native pancreatic exocrine secretion in humans: clinical and metabolic evaluation. Transpl Proc 16: 736 – 738, 1984.
Steiner E, Klima J, Niederwieser D et al: Monitoring of the pancreatic allograft by analysis of exocrine secretion. Transpl Proc 19: 2336 – 2338, 1987.
Calne RY: Paratopic segmental pancreas grafting: a technique with portal venous drainage. Lancet 1: 595 – 597, 1984.
Sutherland DER, Goetz FC, Moudry KC, Abouna GM, Najarian JS: Use of recipient mesenteric vessels for revascularization of segmental pancreas grafts: technical and metabolic considerations. Transpl Proc 19: 2300 – 2304, 1987.
Groth CG, Collste H, Lundgren G et al: Successful outcome of segmental human pancreatic transplantation with enteric exocrine diversion after modifications in technique. Lancet 2: 522 – 524, 1982.
Gil-Vernet JM, Fernandez–Cruz L, Andreu J, Figuerola D, Caralps A: Urinary tract diversion (UTD) in clinical pancreas transplantation. Transpl Proc 18: 1132 – 1133, 1986.
Sollinger H, Kalayoglu M, Hoffman RM et al: Experience with whole pancreas transplantation and pancreaticoduodenocystostomy. Transpl Proc 18: 1759 – 1761, 1986.
Prieto M, Sutherland DER, Fernandez–Cruz L et al: Experimental and clinical experience with urinary amylase monitoring for early diagnosis of rejection in pancreas transplantation. Transplantation 43: 71 – 79, 1987.
Deierhoi MH, Sollinger HW, Bozdec MJ et al: Lethal graft versus host disease in a recipient of pancreas–spleen transplant. Transplantation 41: 544 – 546, 1986.
Starzl TE, Iwatsuki S, Shaw BW: Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet 159: 265, 1984.
Koostra G, von Hooff JP, Jorning PJG et al: A new variant for whole pancreas grafting. Transpl Proc 19: 2314 – 2318, 1987.
Calne RY, McMaster P, Rolles K et al: Technical observations in segmental pancreas transplantation: observations on blood flow. Transpl Proc 12 (Suppl 2): 51 – 57, 1980.
du Toit DF, Heydenrych J, Smit B, Louw G, Zuurmond T, Laker L. Els D, Weideman A, Wolfe-Coote S, van der Merwe EA, Groenewald WA: Segmental pancreatic allograft survival in baboons treated with combined irradiation and cyclosporin: a preliminary report. Surgery, 97 (4): 447–453.
Harris MI, Hanaman RF: Diabetes in America. NIH Publication 85–1468, Bethesda, Maryland 1985.
Goetz FC, Elick B, Fryd D, Sutherland DER: Renal transplantation in diabetes. Clinics in endocrinology and metabolism 15: 807 – 821, 1986.
Sutherland DER, Fryd DS, Payne WD, Ascher N, Simmons RL, Najarian JS: Kidney transplantation in diabetic patients. Transpl Proc 19: 90 – 94, 1987.
Ramsay RC, Cantril HC, Knobloch WH, Goetz FC, Sutherland DER, Najarian JS: Visual parameters in diabetic patients following renal transplantation. Diabetic nephropathy 2 (1): 26 – 29, 1983.
van der Vliet JA, Navarro X, Kennedy WR, Goetz FC, Najarian JS, Sutherland DER: The effect of pancreas transplantation on diabetic polyneuropathy. Transplantation 45: 368 – 370, 1988.
Mauer SM, Steffes MW, Connett J et al: Development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patients. Diabetes 32: 948 – 952, 1983.
Sutherland DER, Bentley FR, Mauer SM, Menth L, Nylander W, Goetz FC, Barbosa J, Ascher NL, Simmons RL, Najarian JS: A report of 26 diabetic renal allograft recipients alive with functioning grafts at 10 or more years after primary transplantation. Diabetic nephropathy 3: 39 – 43, 1984.
Bohman SO, Tyden G, Wilczek A: Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 34: 306, 1985.
Bilous RW, Mauer SM, Sutherland DER et al: The effects of pancreas transplantation on renal allograft glomerular structure in insulin-dependent (type I) diabetes mellitus. Diabetes 38 (Suppl 1): 262, 1989.
Ramsay RC, Goetz FC, Sutherland DER, Mauer SM, Robinson LL, Cantrill HL, Knobloch WH, Najarian JS: Progression of diabetic retinopathy after pancreas transplantation for insulin–dependent diabetes mellitus. New Engl J Med 318: 208 – 214, 1988.
Ulbig M, Kampik A, Landgraf R, Land W: The influence of combined pancreatic and renal transplantation on advanced diabetic retinopathy. Transpl Proc 19: 3554 – 3556, 1987.
Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O: Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Brit Med J 293: 1195– 1199, 1986.
Bilous RW, Mauer SM, Sutherland DER, Steffes MW: Glomerular structure and function following successful pancreas transplantation for insulin-dependent diabetes. Diabetes 36: 43 A, 1987.
DeFrancisco AM, Mauer SM, Steffes MW, Goetz FC, Najarian, JS, Sutherland DER: The effect of cyclosporin on native renal function in nonuremic diabetic recipients of pancreas transplants. J Diab Compl 1: 128 – 131, 1987.
Viberti GC, Hill RD, Jarre HRJ et al: Microalbuminuria as a predictor of clinical diabetic nephropathy. Lancet 1: 1430 – 1432, 1982.
Luetscher JA, Kraemer FS, Wilson DM et al: Increased plasma inactive renin: a marker to microvascular disease. New Engl J Med 312 - 1412, 1985.
Merimee TJ, Zapf J, Froesch ER: Insulin-like growth factors: studies in diabetes with and without retinopathy. New Engl J Med 309: 527, 1983.
Rosenbloom AL, Silverstein JH, Lezotte DC et al: Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. New Engl J Med 305: 191, 1981.
Ungar RH: Meticulous control of diabetes: Benefits, risks and precautions. Diabetes 31: 479, 1982.
White N, Skor DA, Cryer PE et al: Identification for type I diabetic patients at increased risk for hypoglycemia during intensive therapy. New Engl J Med 308: 485, 1983.
Health Care Financing Administration (HCFA) office of special programs: End-stage renal disease program medical information system, facility survey tables, department of health and human services, USA, HCFA, January 1-December 31, 1986.
Bart KJ, Macon EJ, Whittier FC et al: Cadaveric kidneys for transplantation. A paradox of shortage in the face of plenty. Transplantation 31: 374, 1981.
Lacy PE: Islet transplantation. Diabetes annual 3, pp 189 – 200, 1987.
Sutherland DER, Matas AJ, Goetz FC et al: Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes 29 (Suppl 1): 34, 1980.
Scharp DW, Lacy PE: Human islet isolation and transplantation. Diabetes 34 (Suppl 1 ): 5A, 1985.
Faustman D, Hauptfeld V, Lacy P, Davie J: Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to la determinants. Proc Natl Acad Sci USA 78: 5156.
Gores PF, Sutherland DER, Piatt JL, Bach FH: Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival. J Immunol 137: 1482 – 1485, 1986.
Scharp DW, Lacy PE, Finke E et al: Low temperature culture of human islets isolated by the distention method and purified with ficoll or percoll gradients. Surgery 102: 869 – 879, 1987.
Sibley RK, Sutherland DER, Goetz FC, et al: Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscope and immunohistochemical analysis of four cases. Lab Invest 53: 132 – 144, 1985.
Sutherland DER, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38 (Suppl 1): 85 – 87, 1989.
Barker CF, Naji A, Perloff LJ et al: Invited commentary: An overview of pancreas trans-plantation. Biologic aspects. Surgery 92: 113, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Dubernard, J.M., Sutherland, D.E.R. (1989). Perspectives in pancreatic transplantation. In: Dubernard, J.M., Sutherland, D.E.R. (eds) International Handbook of Pancreas Transplantation. Developments in Surgery, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1083-6_38
Download citation
DOI: https://doi.org/10.1007/978-94-009-1083-6_38
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6977-9
Online ISBN: 978-94-009-1083-6
eBook Packages: Springer Book Archive